How HIV-1 lentivirus causes immune deficiency disease

Area of Science:

• Immunology
• Virology
• Genetics

Background:

• Human immunodeficiency virus (HIV-1) infection leads to immune deficiency, sharing characteristics with chronic graft-versus-host disease (GVHD).
• This immune deficiency is associated with human leukocyte antigen (HLA) class 2 incompatibility.
• A specific HIV-1 envelope glycoprotein fragment mimics HLA class 1 C molecules and T cell epitopes within the HLA DR beta chain.

Purpose of the Study:

• To hypothesize the link between viral load, acquired immune deficiency syndrome (AIDS) progression, and immune deficiency severity with specific HLA B and HLA DR beta chain haplotypes in HIV-1 infected patients.
• To investigate the role of HLA class 1 B restricted CD8+ T cells in HIV-1 associated immune suppression.
• To predict the association between specific HLA DR beta chain allotypes and the severity of immune deficiency.

Main Methods:

• Analysis of HLA class 1 B and HLA DR beta chain haplotypes in HIV-1 infected patients.
• Investigation of the mimicry between HIV-1 envelope glycoprotein fragments and HLA molecules.
• Prediction of peptide binding to HLA class 1 B alleles.

Main Results:

• The study hypothesizes a connection between viral parameters and clinical outcomes with HLA B and HLA DR beta chain haplotypes.
• Immune suppression is proposed to be mediated by HLA class 1 B restricted CD8+ T cells.
• Severity of immune deficiency is predicted to correlate with specific HLA DR beta chain allotypes expressing glutamine at position 70.

Conclusions:

• Specific HLA B and HLA DR beta chain variations are hypothesized to influence the clinical course of HIV-1 infection.
• Understanding these HLA associations may provide insights into the mechanisms of HIV-1 associated immune deficiency.
• Further research is warranted to validate the predicted links between HLA allotypes and disease severity.